Peptide Therapy in Dubai
Medilife provides peptide therapy in Dubai through a product-specific care pathway. Different peptides have different uses, evidence, safety considerations and methods of administration, so the right option should be considered individually rather than treating peptide therapy as one standard treatment.
Explore available peptide options, compare current Medilife prices and enquire about assessment before proceeding.
01
Serving Dubai since 2016
02
Product-specific assessment
03
Transparent peptide pricing
What Is Peptide Therapy?
Peptides are short chains of amino acids. In the body, naturally occurring peptides can take part in signalling between cells and in many biological processes. Medical and peptide-based products may use specific peptides or peptide-related compounds for very different clinical purposes.
“Peptide therapy” is therefore a broad term. It can include different products, formulations and routes of administration. Some products have established medical applications, while others have more limited human evidence or are still discussed mainly in research and wellness settings.
For patients, the important question is not simply whether a product is called a peptide. It is which peptide is being considered, why it is being considered, what evidence supports that use, what risks apply and whether the product is appropriate for the individual.
Why Different Peptides Are Not Interchangeable
GHK-Cu, PT-141, CJC-1295, Ipamorelin, BPC-157 and Thymosin Alpha-1 are different compounds. They should not be grouped together under one list of promised “peptide therapy benefits”.
Their biological targets, evidence, possible adverse effects, contraindications, formulations and regulatory position can differ. This is why Medilife's peptide pathway is organised around the specific product rather than a one-size-fits-all protocol.
Peptide Therapy Options at Medilife
Medilife's peptide therapy hub connects you to dedicated information about individual peptide options. Each page focuses on that compound rather than repeating a generic set of claims.
GHK-Cu is a copper-binding tripeptide. Its evidence and applications depend on the formulation and route being considered, so topical research should not automatically be applied to injectable use. Explore the dedicated GHK-Cu page for product-specific information and current options.
PT-141, also known as bremelanotide, acts through melanocortin signalling and is associated with sexual-health medicine. Suitability, indication and regulatory status should be considered for the exact product and patient rather than using general libido-enhancement claims.
CJC-1295 and Ipamorelin are associated with growth-hormone signalling pathways but are not the same compound. Their potential use requires careful assessment of the individual product, available evidence and relevant monitoring considerations.
BPC-157 is widely discussed online in relation to tissue and recovery research, but popular claims can go beyond the available human evidence. The dedicated page explains the product more cautiously, including evidence limitations and safety considerations.
Thymosin Alpha-1 is associated with immune-related biological pathways. It should not be presented simply as a product that “boosts immunity”. Any clinical use needs to be considered in the context of the exact product, intended purpose and individual patient.
These are the core peptide options currently represented in Medilife's peptide therapy service architecture.
Additional Peptide Options
Medilife also has current product information for Tesamorelin and MOTS-C.
Tesamorelin is a growth hormone-releasing hormone analogue with specific established medical use in some jurisdictions. That should not be generalised into a routine weight-loss claim.
MOTS-C is a mitochondrial-derived peptide associated with metabolic and cellular stress-response research. Human evidence for commonly promoted wellness applications remains limited.
These products do not yet have separate approved Medilife page URLs, so more detailed information should be confirmed directly with the Medilife team.
How an At-Home Peptide Therapy Visit Works
Patients searching for peptide therapy at home in Dubai should first confirm whether the specific product and their individual care needs are suitable for a home-care pathway. Not every peptide, formulation or patient should be assumed to be appropriate for administration at home.
Screening and Suitability
The process begins with clinical screening. Relevant information may include your medical history, current medicines, health conditions and the reason the peptide is being considered.
The purpose is to determine whether the requested option is appropriate and whether further assessment is needed before proceeding. Peptide treatment should not begin simply because a particular product is popular online.
Consent and the Nurse Visit
Where a specific peptide service is suitable and authorised for home administration, the patient should understand the product being considered, its limitations, relevant risks and alternatives before treatment.
A nurse or other appropriate healthcare professional may then be involved in the patient-visible care pathway according to the product and clinical plan. Medilife does not provide self-injection instructions on this page. The exact home-care availability and professional scope should be confirmed for the requested peptide before booking.
Are Blood Tests Needed Before Peptide Therapy?
Not everyone needs the same laboratory tests before peptide therapy.
Blood testing may be useful when the clinician needs additional information for baseline assessment, treatment suitability or monitoring. The required investigations depend on the specific peptide, the reason it is being considered and the patient's health history.
Testing should therefore be clinically relevant rather than added routinely to every peptide programme.
Peptide Therapy Cost in Dubai
There is no single price for peptide therapy because Medilife offers different products and formulations. Current supplied prices include:
GHK-Cu
- Formulation
- Vial injectable
- Price
- AED 1,375
GHK-Cu
- Formulation
- Pen
- Price
- AED 1,575
PT-141
- Formulation
- Nasal spray
- Price
- AED 975
PT-141
- Formulation
- Vial injectable
- Price
- AED 1,375
PT-141
- Formulation
- Pen options
- Price
- AED 1,175–1,575
CJC-1295
- Formulation
- Vial
- Price
- AED 1,375
CJC-1295
- Formulation
- Pen
- Price
- AED 1,575
CJC-1295
- Formulation
- Nasal spray
- Price
- AED 1,575
BPC-157
- Formulation
- Vial
- Price
- AED 1,575
BPC-157
- Formulation
- Pen
- Price
- AED 1,725
Tesamorelin
- Formulation
- Vial
- Price
- AED 1,400
Tesamorelin
- Formulation
- Pen
- Price
- AED 1,550
MOTS-C
- Formulation
- Vial
- Price
- AED 2,475
MOTS-C
- Formulation
- Pen
- Price
- AED 2,575
| Peptide | Formulation | Price |
|---|---|---|
| GHK-Cu | Vial injectable | AED 1,375 |
| GHK-Cu | Pen | AED 1,575 |
| PT-141 | Nasal spray | AED 975 |
| PT-141 | Vial injectable | AED 1,375 |
| PT-141 | Pen options | AED 1,175–1,575 |
| CJC-1295 | Vial | AED 1,375 |
| CJC-1295 | Pen | AED 1,575 |
| CJC-1295 | Nasal spray | AED 1,575 |
| BPC-157 | Vial | AED 1,575 |
| BPC-157 | Pen | AED 1,725 |
| Tesamorelin | Vial | AED 1,400 |
| Tesamorelin | Pen | AED 1,550 |
| MOTS-C | Vial | AED 2,475 |
| MOTS-C | Pen | AED 2,575 |
A separate Ipamorelin price and Thymosin Alpha-1 price are not stated here.
What Can Affect the Total Cost?
The product and formulation are only part of the cost question. Depending on the care pathway, patients may also need to ask whether assessment, laboratory investigations, professional administration, follow-up or delivery are charged separately.
These items should not be assumed to be included in the product price. Contact Medilife for the current cost of the exact peptide option you are considering.
Safety, Suitability and Evidence for Peptide Therapy
A safer way to evaluate peptide therapy is to look at the exact compound rather than relying on broad claims about “peptides”.
The clinical assessment should consider why the product is being proposed, what evidence exists for that purpose, relevant medical conditions, current medicines, potential adverse effects and whether the selected route is appropriate.
Some peptide-related medicines have well-defined clinical uses. Other compounds promoted for recovery, longevity, body composition or general wellness have much less human evidence. A product being discussed online or sold in a particular formulation does not, by itself, establish that it is suitable for a person or effective for a proposed goal.
- 01
Evidence Varies by Peptide and Intended Use
Evidence for one peptide cannot be transferred to another.
Human clinical trials provide more useful evidence for patient care than laboratory or animal studies alone. Early biological research can help explain why a compound is being studied, but it does not automatically prove meaningful benefit in people.
This distinction is particularly important for peptides promoted for healthy ageing, recovery, metabolic optimisation or tissue repair. Medilife's individual peptide pages provide more specific context where appropriate.
- 02
Who May Need Extra Clinical Review?
Additional review may be important if you are pregnant or breastfeeding, take regular medicines, use hormone-related treatments, have an endocrine or metabolic condition, have significant chronic illness or have previously experienced medication reactions.
This is not a complete exclusion list. Suitability depends on the exact product and your clinical circumstances.
Peptide Therapy and UAE Regulation
Peptide regulation in Dubai and the wider UAE is product-specific.
A healthcare facility's licence, a healthcare professional's licence and authorisation of a particular medicinal product are separate matters. The fact that care is delivered by a healthcare provider does not mean that every peptide product, indication or formulation has the same regulatory status.
The Dubai Health Authority and the Emirates Drug Establishment have different roles within the healthcare and medicinal-product regulatory system. Before proceeding, the exact peptide, source, intended use and applicable prescribing or supply pathway should be checked.
For a more detailed explanation, read Are Peptides Legal and Safe in the UAE?.
Why Choose Medilife for Peptide Care in Dubai?
Medilife has been serving patients in Dubai since 2016. The wider Medilife organisation has served more than 47,000 patients and reports a 99.8% patient satisfaction rate.
For peptide care, the focus is on making the specific product clear before treatment is considered. That includes separating one peptide from another, showing available formulations and prices, and recognising that evidence, suitability and regulatory requirements can differ.
Medilife also makes it easier to compare the individual peptide pathways rather than relying on a generic package of anti-ageing, recovery or wellness claims.
You can also see patient feedback about Medilife on Google and Trustpilot.
Frequently Asked Questions About Peptide Therapy
Peptide therapy is a broad term for healthcare involving a specific peptide or peptide-related product. Peptides are chains of amino acids, but individual products can work in very different ways. Their evidence, risks, formulations and appropriate uses also differ, so peptide therapy should be considered product by product rather than as one uniform treatment.
The price depends on the peptide and formulation. Current Medilife prices shown on this page range from AED 975 for one PT-141 nasal-spray option to AED 2,575 for a MOTS-C pen. This is not a universal treatment range, and separate assessment, tests or other care should not be assumed to be included.
Home care may be possible for selected peptide services when the specific product, route and patient are appropriate for that setting. Suitability should be confirmed before booking. The care pathway may involve screening, consent and a nurse or other appropriate healthcare professional, depending on the exact service.
There is no accurate blanket answer for every peptide. Regulatory status can depend on the exact product, formulation, intended use, prescribing pathway and applicable UAE requirements. Facility licensing and product authorisation are separate issues. Check the specific product rather than relying on a general claim that “peptides are legal” or “DHA approved”.
It depends on the peptide and the purpose for which it is being considered. Some peptide-related medicines have established clinical evidence for specific indications, while other compounds promoted for wellness or recovery have limited human data. A claim that applies to one product should not be generalised to all peptide therapy.
No. Injection is one possible route of administration. Peptide-related products may also be supplied in other formulations, depending on the specific product. Medilife's current range includes injectable, pen and selected nasal-spray formulations. The route should be considered as part of the product-specific clinical pathway.
Not automatically. Blood tests may be requested when they are relevant to the peptide being considered, your medical history or the need for baseline or follow-up information. The appropriate tests, if any, should be determined by the clinical assessment rather than added to every peptide service as a standard package.
The current peptide therapy pathway includes dedicated information for GHK-Cu, PT-141, CJC-1295 with Ipamorelin, BPC-157 / Pentadeca Arginate and Thymosin Alpha-1. Medilife also has product information and pricing for Tesamorelin and MOTS-C. The appropriate option depends on the specific clinical and regulatory pathway.
Discuss Peptide Therapy With Medilife
If you are considering peptide therapy in Dubai, start with the specific product you are interested in rather than a general promise about peptide benefits.
Medilife can help you discuss the available option, current price and the next assessment step, including whether home care may be appropriate for that particular service.
Find us & get in touch
Visit Medilife Healthcare Services LLC or contact our team about the care you need.
Our location
Medilife Healthcare Services LLC
DHA-licensed healthcare provider offering 24/7 home healthcare services in Dubai. Our team is ready to deliver comprehensive medical support to your location.